Stockscreener 앱 받기
4.05
3.85%
0.15
전일 마감가:
$3.90
열려 있는:
$3.88
하루 거래량:
199.03K
Relative Volume:
0.89
시가총액:
$97.49M
수익:
$52.29M
순이익/손실:
$-73.52M
주가수익비율:
-6.1364
EPS:
-0.66
순현금흐름:
$-100.45M
1주 성능:
+3.32%
1개월 성능:
-15.98%
6개월 성능:
-10.40%
1년 성능:
-14.19%
1일 변동 폭
$3.774
$4.1199
1주일 범위
$3.7484
$4.1883
52주 변동 폭
$3.7484
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
명칭
Precision Biosciences Inc
전화
919-314-5512
주소
302 EAST PETTIGREW STREET, DURHAM, NC
DTIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
4.05 | 93.88M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | 개시 | Guggenheim | Buy |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-09 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | 재개 | BTIG Research | Buy |
| 2020-04-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-05 | 개시 | Stifel | Buy |
| 2020-02-25 | 개시 | William Blair | Outperform |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | H.C. Wainwright | Buy |
| 2019-04-22 | 개시 | Barclays | Overweight |
| 2019-04-22 | 개시 | Goldman | Buy |
| 2019-04-22 | 개시 | JP Morgan | Overweight |
| 2019-04-22 | 개시 | Jefferies | Buy |
모두보기
Precision Biosciences Inc 주식(DTIL)의 최신 뉴스
Aug Levels: How does Precision BioSciences Inc perform in inflationary periods2025 Dividend Review & Fast Gain Swing Alerts - baoquankhu1.vn
Trend Recap: Will Precision BioSciences Inc stock benefit from green energy trends2025 Price Action Summary & Technical Pattern Based Signals - Bộ Nội Vụ
Precision BioSciences Highlights 2026 Gene Editing Priorities - TipRanks
Precision BioSciences advances gene editing programs with key milestones By Investing.com - Investing.com Nigeria
Aug Catalysts: Is Precision BioSciences Inc stock trending bullishPortfolio Value Summary & Detailed Earnings Play Strategies - baoquankhu1.vn
Precision BioSciences advances gene editing programs with key milestones - Investing.com
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy - Business Wire
Will Precision BioSciences Inc. stock outperform Nasdaq indexMarket Performance Recap & Detailed Earnings Play Alerts - Улправда
Can Precision BioSciences Inc. (PBS0) stock deliver strong annual returns2025 Short Interest & Accurate Buy Signal Alerts - Улправда
Can Precision BioSciences Inc. stock reach $100 price targetJuly 2025 Price Swings & Verified Swing Trading Watchlists - Улправда
Is Precision BioSciences Inc. stock a top pick in earnings seasonEarnings Performance Report & AI Driven Price Forecasts - Улправда
Will Precision BioSciences Inc. stock split again soon2025 Winners & Losers & Low Drawdown Investment Strategies - Улправда
How Precision BioSciences Inc. stock compares to market leadersWeekly Market Outlook & Smart Swing Trading Techniques - Улправда
Can Precision BioSciences Inc. stock hit analyst price targetsQuarterly Trade Review & Low Drawdown Investment Ideas - Улправда
Is Precision BioSciences Inc. (PBS0) stock a top hedge fund pickIPO Market Watch & Free High Yield Investment Strategies - Улправда
Precision BioSciences: Tiny Gene-Editing Stock Caught Between Deep Cuts and Big Optionality - AD HOC NEWS
Precision Bio's DMD Therapy Gets Rare Pediatric Status, But Stock Slides; Retail Crowd Sees ‘Good Risk-Reward’ - MSN
What drives Precision BioSciences Inc PBS0 stock priceSell Signals and Alerts & Low Cost Portfolio Tips - earlytimes.in
Sterling Tools Limited Ranks High in Smart Money TrackerFundamental Strength Indicators & Explosive Profit Growth - earlytimes.in
Aug Ideas: Is Precision BioSciences Inc stock a top pick in earnings season - moha.gov.vn
Short Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Expands By 27.4% - MarketBeat
Earnings Update: Is Precision BioSciences Inc stock a top pick in earnings seasonWeekly Earnings Recap & Consistent Profit Trading Strategies - Bộ Nội Vụ
Precision Biosciences Inc files for mixed shelf of up to $250 millionSEC filing - MarketScreener
Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha
Will Precision BioSciences Inc. stock benefit from infrastructure spendingMarket Breadth Indicators & Investor Community Interactions - bollywoodhelpline.com
Can Precision BioSciences Inc. stock maintain operating marginsEarnings Volatility Patterns & Affordable Stock Picks - bollywoodhelpline.com
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - 01net
What analysts say about Precision BioSciences Inc PBS0 stockInstitutional Buying Trends & Free Explosive Trading Growth - earlytimes.in
Precision BioSciences Earnings Notes - Trefis
Will Precision BioSciences Inc. stock gain from government policies2025 Price Targets & Free Safe Capital Growth Stock Tips - Улправда
How Precision BioSciences Inc. stock compares to industry benchmarksWeekly Investment Summary & Weekly Watchlist for Consistent Profits - Улправда
How Precision BioSciences Inc. stock reacts to global recession fearsNew Guidance & Technical Pattern Based Buy Signals - DonanımHaber
Market Recap: How Precision BioSciences Inc. stock reacts to global recession fears2025 Price Targets & Scalable Portfolio Growth Methods - DonanımHaber
Aug Shorts: Will Precision BioSciences Inc. stock benefit from infrastructure spendingPortfolio Update Report & Free Technical Pattern Based Buy Signals - Улправда
Street Watch: Is Precision BioSciences Inc. (PBS0) stock a top hedge fund pick2025 Key Highlights & Daily Profit Maximizing Tips - ulpravda.ru
Precision BioSciences (NASDAQ:DTIL) Director Geno Germano Buys 3,000 Shares - MarketBeat
Insider Buying: Stanley Frankel Acquires Additional Shares of Pr - GuruFocus
Insider Buying: Precision BioSciences (NASDAQ:DTIL) Director Acquires $12,690.00 in Stock - MarketBeat
Dir Germano Buys 3,000 ($14.2K) Of Precision BioSciences Inc [DTIL] - TradingView — Track All Markets
Dir Brown Buys 1,381 ($6.9K) Of Precision BioSciences Inc [DTIL] - TradingView — Track All Markets
Precision Biosciences Executives Increase Holdings - TradingView — Track All Markets
Precision Biosciences (DTIL) director adds 3,000 shares in open-market buy - Stock Titan
Precision BioSciences (DTIL) director reports purchase of 2,700 shares - Stock Titan
Precision BioSciences (DTIL) director reports purchase of 1,381 shares - Stock Titan
Financial Analysis: Precision BioSciences (NASDAQ:DTIL) & Upstream Bio (NASDAQ:UPB) - Defense World
Precision BioSciences (DTIL) Receives a Rating Update from a Top Analyst - The Globe and Mail
Aug Summary: Can Precision BioSciences Inc stock hit analyst price targetsWeekly Trading Summary & Reliable Breakout Stock Forecasts - moha.gov.vn
Sidoti Events, LLC's Year-End Virtual Investor Conference - Yahoo Finance
Precision Biosciences Inc (DTIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Precision Biosciences Inc 주식 (DTIL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Frankel Stanley | Director |
Dec 16 '25 |
Buy |
4.70 |
2,700 |
12,690 |
19,478 |
| Brown Melinda | Director |
Dec 15 '25 |
Buy |
4.97 |
1,381 |
6,864 |
23,346 |
| Kelly John Alexander | Chief Financial Officer |
Nov 02 '25 |
Option Exercise |
0.00 |
3,605 |
0 |
78,601 |
| Kelly John Alexander | Chief Financial Officer |
Nov 03 '25 |
Sale |
6.49 |
1,303 |
8,456 |
77,298 |
| Scimeca Dario | General Counsel and Secretary |
Nov 02 '25 |
Option Exercise |
0.00 |
1,835 |
0 |
28,923 |
| Scimeca Dario | General Counsel and Secretary |
Nov 03 '25 |
Sale |
6.49 |
665 |
4,316 |
28,258 |
| Amoroso Michael | President and CEO |
Nov 02 '25 |
Option Exercise |
0.00 |
9,444 |
0 |
118,984 |
| Amoroso Michael | President and CEO |
Nov 03 '25 |
Sale |
6.49 |
3,409 |
22,124 |
115,575 |
4.73%
0.92%
자본화:
|
볼륨(24시간):